To identify whether there were any downstream targets transcriptionally regulated by the BRMS1 mutant proteins; we performed breast cancer disease specific arrays (DSATM, Almac Diagnostics, Durham, NC). This evidence concerns the gene BRMS1 and breast carcinoma.